A phase I/II trial of ZD1839 (Iressa) given concurrently with cisplatin and radiotherapy in patients with locally advanced head and neck cancer
Phase of Trial: Phase I/II
Latest Information Update: 14 Dec 2007
At a glance
- Drugs Cisplatin; Gefitinib
- Indications Head and neck cancer
- Focus Adverse reactions; Therapeutic Use
- Sponsors AstraZeneca
- 31 Aug 2018 Biomarkers information updated
- 14 Dec 2007 Status changed from in progress to completed.
- 22 Dec 2005 New trial record.